# Certis Biologicals

广谱生物控制 — 微生物发酵.

Source: https://cn.bioecon.ru/companies/certis-biologicals/
Updated: 2026-06-24

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 无风险融资轮次；2001年通过收购Thermo Trilogy成为三井物产的全资子公司。 | https://biobase.whitefordresearch.com/companies/certis-biologicals |
| 生产基地 | 三家生产工厂：美国两家（加州Wasco与蒙大拿州Butte），印度一家合资工厂。 | https://www.certisbio.com/, https://www.certisbio.com/about-certis-biologicals, https://www.certisbio.com/hubfs/CRT_Infographic_2021%20USA%20Product%20List_R2.pdf, https://www.certisbio.com/hubfs/Leading%20Biologicals%20Periodic%20Table%20_DIGITAL%200625%20.pdf, https://www.certisbio.com/manufacturing-and-technology |
| 产能 | 加大对发酵与配方产能的投资，以提升性能与一致性。 | https://www.certisbio.com/manufacturing-and-technology, https://www.news.market.us/bioherbicides-market-news/ |
| 监管批准 | 维持庞大的全球注册组合；2025年3月宣布NemaClean首次获欧盟授权。 | https://biobase.whitefordresearch.com/companies/certis-biologicals, https://www.certisbio.com/, https://www.certisbio.com/20years, https://www.certisbio.com/manufacturing-and-technology |
| 认证 | 拥有大量列入OMRI名录的产品；加州Wasco基地通过ISO 9001:2015认证。 | https://www.certisbio.com/, https://www.certisbio.com/hubfs/CRT_Infographic_2021%20USA%20Product%20List_R2.pdf, https://www.certisbio.com/hubfs/Leading%20Biologicals%20Periodic%20Table%20_DIGITAL%200625%20.pdf, https://www.certisbio.com/manufacturing-and-technology |
| 员工人数 | 已报告的区间不一，约从139名员工（截至2026年4月）到250-300名员工（2024年）。 [中等置信度] | https://www.certisbio.com/hubfs/CRT_Infographic_2021%20USA%20Product%20List_R2.pdf, https://www.news.market.us/bioherbicides-market-news/ |
| 营收 | 已报告的估计不一，从$30M-$100M到$140M-$170M（2023-2024年）。 [中等置信度] | https://www.news.market.us/bioherbicides-market-news/ |

独立来源: biobase.whitefordresearch.com, news.market.us

## 技术

- [动物微生物组与噬菌体制剂](https://cn.bioecon.ru/technology/microbiome-phage-preparations-animals/)
- [生物肥料与生物农药](https://cn.bioecon.ru/technology/biofertilizers-biopesticides/)
- [生物除草剂与生态杂草控制](https://cn.bioecon.ru/technology/bioherbicides-ecological-weed-control/)